Phibro Animal Health (PAHC) Total Non-Current Liabilities (2013 - 2026)

Phibro Animal Health (PAHC) recorded quarterly Total Non-Current Liabilities of $1.1 billion in Q1 2026, up 1.07% quarter-over-quarter from $1.1 billion in Q4 2025, and up 4.13% on a YoY basis from $1.0 billion in Q1 2025.

Phibro Animal Health (PAHC) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends

Phibro Animal Health's Total Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities rose 4.13% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 4.13% YoY), while the FY2025 annual figure was $995.9 million, up 38.57% from the prior year.
  • Total Non-Current Liabilities was $1.1 billion for Q1 2026 at Phibro Animal Health, up from $1.1 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $1.1 billion in Q1 2026 to a low of $608.8 million in Q2 2022.
  • Historically, Total Non-Current Liabilities has averaged $796.9 million across 5 years, with a median of $701.9 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities retreated 6.97% in 2023, then soared 52.4% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $684.3 million in 2022, then decreased by 6.97% to $636.6 million in 2023, then jumped by 52.4% to $970.1 million in 2024, then advanced by 10.36% to $1.1 billion in 2025, then increased by 1.07% to $1.1 billion in 2026.
  • The last three Total Non-Current Liabilities figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 18.28 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.44 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.81 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.13 Bn
10 Phibro Animal Health 1.32 Bn 1.24 Bn 125.68 Mn 1.08 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.08 Bn
Dec 31, 2025 1.07 Bn
Sep 30, 2025 1.06 Bn
Jun 30, 2025 995.91 Mn
Mar 31, 2025 1.04 Bn
Dec 31, 2024 970.13 Mn
Sep 30, 2024 707.11 Mn
Jun 30, 2024 718.70 Mn
Mar 31, 2024 701.94 Mn
Dec 31, 2023 636.59 Mn
Sep 30, 2023 631.07 Mn
Jun 30, 2023 682.81 Mn
Mar 31, 2023 686.96 Mn
Dec 31, 2022 684.29 Mn
Sep 30, 2022 624.24 Mn
Jun 30, 2022 608.76 Mn
Mar 31, 2022 643.51 Mn
Dec 31, 2021 603.79 Mn
Sep 30, 2021 546.60 Mn
Jun 30, 2021 546.83 Mn